Ethics and Research Integrity

Authorship Criteria

Elevate recommends that authorship follow the ICMJE criteria. Each author should have made substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; contributed to drafting the work or revising it critically; approved the final version; and agreed to be accountable for all aspects of the work. Individuals who do not meet all authorship criteria should be acknowledged, with their permission, where appropriate.

Author Contributions (CRediT)

Authors should provide a statement describing individual contributions using the CRediT taxonomy where applicable. Roles may include conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing – original draft, writing – review and editing, visualization, supervision, project administration, and funding acquisition. Not every role applies to every manuscript.

Ethical Approval and Human Participants

Research involving human participants, identifiable human data, or human biological materials must comply with applicable ethical standards and institutional and national requirements. Authors must state whether approval was obtained from a recognized research ethics committee or institutional review board. The statement should identify the committee, institution, approval or reference number, and approval date. If formal review was not required, authors must explain the basis for the exemption or provide documentation from the responsible ethics body when available.

The Methods section should describe how informed consent was obtained, including whether consent was written or verbal. For research involving children or individuals unable to provide legally valid consent, authors should explain how permission from a parent or legally authorized representative and assent, where appropriate, were obtained. Participant privacy and confidentiality must be protected.

Case Reports and Patient Consent

Case reports must include a statement confirming that written informed consent for publication was obtained from the patient or legally authorized representative when required. Authors must remove identifying details unless their inclusion is essential and explicit consent has been obtained. Consent to participate in clinical care is not equivalent to consent to publish a case report.

Clinical Trial Registration

Prospective clinical trials must be registered in a publicly accessible registry recognized by the World Health Organization International Clinical Trials Registry Platform or an equivalent registry accepted by the journal. Registration should occur before the first participant is enrolled. Authors must provide the registry name, registration number, and registration date in the manuscript. The Editor-in-Chief may consider exceptional circumstances involving delayed registration, but retrospective registration does not automatically satisfy prospective registration requirements.

Conflicts of Interest

All authors must disclose financial and non-financial relationships or activities that could reasonably be perceived to influence the research or its interpretation. Examples include employment, consultancies, honoraria, grants, personal relationships, patents, stock ownership, and leadership roles. If no competing interests exist, authors should state: β€œThe authors declare that they have no competing interests.”

Funding

All sources of financial and material support must be disclosed, including grant numbers where applicable. Authors should describe the role of the funder in study design, data collection, analysis, interpretation, manuscript preparation, and the decision to submit. If the funder had no such role, this should be stated. If the work received no specific funding, authors should state that no specific grant was received.

Data Availability and Research Materials

Original Research Articles should include a Data Availability Statement describing whether and how the data supporting the findings can be accessed. Data may be openly available in a repository, available from the corresponding author on reasonable request, restricted because of privacy or ethical obligations, or not applicable. Authors must not disclose identifiable participant information or share data contrary to consent, ethics approval, or law.

Reporting Guidelines

Authors should use the reporting guideline most appropriate to their study design and submit the completed checklist where available. Examples include CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews, PRISMA-ScR for scoping reviews, COREQ or SRQR for qualitative research, CARE for case reports, STARD for diagnostic accuracy studies, TRIPOD for prediction models, ARRIVE for animal research, and SQUIRE for quality improvement studies. Authors should consult the EQUATOR Network for relevant guidance.

Plagiarism, Similarity, and Duplicate Publication

Submitted manuscripts may be screened using plagiarism-detection software. Similarity reports are used as an aid to editorial assessment and are not, by themselves, proof of misconduct. Editors consider the nature, extent, context, attribution, and source of overlapping text. Plagiarism, unattributed reuse, data fabrication, data falsification, image manipulation, duplicate publication, and redundant publication are unacceptable.

A manuscript must not be under consideration by another journal while it is being considered by Elevate. Any prior dissemination, including preprints, conference abstracts, theses, or related publications, must be disclosed at submission. The Editor-in-Chief will assess whether prior dissemination constitutes acceptable preliminary disclosure or duplicate publication.

Use of Generative Artificial Intelligence

Authors must disclose the use of generative AI tools when such tools have contributed to the preparation of the manuscript, including writing, editing, translation, image generation, or data-related tasks. The disclosure should identify the tool and describe its role. AI tools cannot be listed as authors. Authors remain fully responsible for the accuracy, originality, integrity, and validity of the submitted work, including verification of references and factual claims. AI tools must not be used to fabricate or falsify data, results, citations, or images.

Reviewers and editors must protect the confidentiality of submitted manuscripts. They should not upload unpublished manuscripts or confidential review materials to public or third-party AI tools where confidentiality cannot be assured.

Acknowledgments

Contributors who do not meet the authorship criteria may be acknowledged with their permission. Authors should identify the nature of the contribution, including technical assistance, language editing, administrative support, or other non-author contributions. Any paid writing or editorial assistance must be disclosed.

Permissions and Copyrighted Material

Authors are responsible for obtaining written permission to reproduce copyrighted tables, figures, photographs, instruments, or substantial extracts from other sources. Permission must cover the intended online and open-access publication. Evidence of permission should be submitted with the manuscript.

Corrections, Retractions, and Post-publication Concerns

The journal is committed to preserving the integrity of the scholarly record. If a significant error is identified after publication, the journal may publish a correction. If the reliability or integrity of an article is seriously questioned, the journal may publish an expression of concern while an investigation is ongoing. Retraction may be considered when findings are unreliable because of major error or misconduct, or when publication involves serious ethical or legal breaches. Editorial actions will be proportionate, transparent, and guided by recognized publication-ethics principles.

Confidentiality

Editors and reviewers must treat submitted manuscripts and associated communications as confidential. Manuscripts must not be used for personal advantage or shared with unauthorized individuals. Reviewers should not contact authors directly about a submission unless authorized by the editor.